Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Threshold Pharmaceuticals Inc

+ Add to Watchlist

THLD:US

3.5200 USD 0.0300 0.86%

As of 20:10:00 ET on 05/05/2015.

Snapshot for Threshold Pharmaceuticals Inc (THLD)

Open: 3.5000 Day's Range: 3.4700 - 3.5893 Volume: 741,382
Previous Close: 3.4900 52wk Range: 2.5800 - 5.4100 1-Yr Rtn: -9.28%

Stock Chart for THLD

No chart data available.
  • THLD:US 3.5200
  • 1D
  • 1M
  • 1Y
3.4900
Interactive THLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4050
Est. EPS (USD) (12/2015) -0.5100
Est. PEG Ratio -
Market Cap (M USD) 251.10
Shares Outstanding (M) 71.33
30 Day Average Volume 562,250
Price/Book (mrq) -
Price/Sale (ttm) 14.8359
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THLD

Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

Harold E Selick "Barry"Chief Executive OfficerTillman PearceChief Medical Officer
Robert L Simon "Bob"Senior VP:Regulatory AffairsNipun DavarSenior VP:Pharmaceutical Development
More Company Profile & Key Executives for THLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil